Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2024
Home
2024
July 24, 2024
Published by
Dominic Burg
on
July 24, 2024
Categories
Appendix 4C Cash Flow & Activities Report
July 24, 2024
Published by
Dominic Burg
on
July 24, 2024
Categories
AN1 – Company Update Licence Partnership Announcement
July 1, 2024
Published by
Dominic Burg
on
July 1, 2024
Categories
Confirmation of Release – AN1 – Lapse of unlisted options
June 13, 2024
Published by
Dominic Burg
on
June 13, 2024
Categories
Change of Company Secretary
June 12, 2024
Published by
Dominic Burg
on
June 12, 2024
Categories
Midkine Antibody Licensing Deal
May 20, 2024
Published by
Dominic Burg
on
May 20, 2024
Categories
Response to Appendix 3Y Query
May 16, 2024
Published by
AN1 Marketing
on
May 16, 2024
Categories
Change of Director’s Interest Notices
April 29, 2024
Published by
Dominic Burg
on
April 29, 2024
Categories
Quarterly Activities_Appendix 4C Cash Flow Report
April 29, 2024
Published by
Dominic Burg
on
April 29, 2024
Categories
Change in substantial holding – HNG
1
2
3
4
Next page
